| Year |
Citation |
Score |
| 2024 |
López-Canul M, He Q, Sasson T, Ettaoussi M, De Gregorio D, Ochoa-Sanchez R, Catoire H, Posa L, Rouleau G, Beaulieu JM, Comai S, Gobbi G. Selective Enhancement of REM Sleep in Male Rats through Activation of MT Receptors Located in the Locus Coeruleus Norepinephrine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 38744530 DOI: 10.1523/JNEUROSCI.0914-23.2024 |
0.532 |
|
| 2023 |
Pearl-Dowler L, Posa L, Lopez-Canul M, Teggin A, Gobbi G. Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110805. PMID 37257771 DOI: 10.1016/j.pnpbp.2023.110805 |
0.531 |
|
| 2022 |
Gamble MC, Williams BR, Singh N, Posa L, Freyberg Z, Logan RW, Puig S. Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward. Frontiers in Systems Neuroscience. 16: 1059089. PMID 36532632 DOI: 10.3389/fnsys.2022.1059089 |
0.348 |
|
| 2022 |
Rullo L, Caputi FF, Losapio LM, Morosini C, Posa L, Canistro D, Vivarelli F, Romualdi P, Candeletti S. Effects of Different Opioid Drugs on Oxidative Status and Proteasome Activity in SH-SY5Y Cells. Molecules (Basel, Switzerland). 27. PMID 36500414 DOI: 10.3390/molecules27238321 |
0.572 |
|
| 2022 |
Posa L, De Gregorio D, He Q, Lopez-Canul M, Darcq E, Rullo L, Pearl-Dowler L, Luongo L, Candeletti S, Romualdi P, Kieffer BL, Gobbi G. Supraspinal melatonin MT receptor agonism alleviates pain via a neural circuit that recruits mu opioid receptors. Journal of Pineal Research. PMID 35996205 DOI: 10.1111/jpi.12825 |
0.76 |
|
| 2021 |
Rullo L, Posa L, Caputi FF, Stamatakos S, Formaggio F, Caprini M, Liguori R, Candeletti S, Romualdi P. Nociceptive behavior and central neuropeptidergic dysregulations in male and female mice of a Fabry disease animal model. Brain Research Bulletin. 175: 158-167. PMID 34339779 DOI: 10.1016/j.brainresbull.2021.07.027 |
0.509 |
|
| 2021 |
De Gregorio D, Popic J, Enns JP, Inserra A, Skalecka A, Markopoulos A, Posa L, Lopez-Canul M, Qianzi H, Lafferty CK, Britt JP, Comai S, Aguilar-Valles A, Sonenberg N, Gobbi G. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33495318 DOI: 10.1073/pnas.2020705118 |
0.531 |
|
| 2020 |
Caputi FF, Di Cesare Mannelli L, Rullo L, Micheli L, Stamatakos S, Posa L, Ghelardini C, Romualdi P, Candeletti S. The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms. Biochemical Pharmacology. 182: 114255. PMID 33010214 DOI: 10.1016/j.bcp.2020.114255 |
0.527 |
|
| 2020 |
De Gregorio D, Dean Conway J, Canul ML, Posa L, Bambico FR, Gobbi G. Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors. The International Journal of Neuropsychopharmacology. PMID 32725198 DOI: 10.1093/Ijnp/Pyaa058 |
0.674 |
|
| 2020 |
Posa L, Lopez-Canul M, Rullo L, De Gregorio D, Dominguez-Lopez S, Aboud MK, Felicia Caputi F, Candeletti S, Romualdi P, Gobbi G. Nociceptive responses in MT receptor knockout mice compared to MT and double MT /MT receptor knockout mice. Journal of Pineal Research. e12671. PMID 32430930 DOI: 10.1111/Jpi.12671 |
0.7 |
|
| 2020 |
Comai S, De Gregorio D, Posa L, Ochoa-Sanchez R, Bedini A, Gobbi G. Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking MT receptors. Journal of Pineal Research. e12653. PMID 32239546 DOI: 10.1111/Jpi.12653 |
0.598 |
|
| 2019 |
López-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, Gobbi G, Comai S. Melatonin MT and MT Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle. International Journal of Molecular Sciences. 20. PMID 31108968 DOI: 10.3390/Ijms20102452 |
0.607 |
|
| 2019 |
Lopez-Canul M, Sasson T, Ochoa-Sanchez R, He Q, Yin S, De Gregorio D, Posa L, Comai S, Gobbi G. Effect of the selective melatonin MT1 receptor partial agonist UCM871 in the activity of noraphineprine neurons of the locus coeruleus during the sleep/wake cycle Sleep Medicine. 64: S231. DOI: 10.1016/J.Sleep.2019.11.646 |
0.596 |
|
| 2019 |
De Gregorio D, Popic J, Enns J, Posa L, Aguilar-Valles A, Sonenberg N, Gobbi G. S.17.02 Lysergic acid diethylamide reverses anxious-like behaviour and modulates serotonergic neurotransmission in a chronic stress model European Neuropsychopharmacology. 29: S12-S13. DOI: 10.1016/j.euroneuro.2019.09.042 |
0.446 |
|
| 2018 |
De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Progress in Brain Research. 242: 69-96. PMID 30471683 DOI: 10.1016/Bs.Pbr.2018.07.008 |
0.592 |
|
| 2018 |
De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G. Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. PMID 30157131 DOI: 10.1097/J.Pain.0000000000001386 |
0.699 |
|
| 2017 |
Posa L, De Gregorio D, Gobbi G, Comai S. Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Current Medicinal Chemistry. PMID 28183259 DOI: 10.2174/0929867324666170209104926 |
0.655 |
|
| 2017 |
Comai S, Posa L, Ochoa-Sanchez R, Spadoni G, Gobbi G. Neuropsychopharmacological properties of novel melatonin MT1 receptor ligands European Neuropsychopharmacology. 27: S569. DOI: 10.1016/S0924-977X(17)31098-2 |
0.58 |
|
| 2017 |
De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G. D-lysergic diethylamide modulates dopaminergic neurons of ventral tegmental area via 5-HT1A, D2 and TAAR1 receptors European Neuropsychopharmacology. 27: S53-S54. DOI: 10.1016/S0924-977X(17)30124-4 |
0.691 |
|
| 2016 |
De Gregorio D, Comai S, Posa L, Gobbi G. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. International Journal of Molecular Sciences. 17. PMID 27886063 DOI: 10.3390/Ijms17111953 |
0.613 |
|
| 2016 |
De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors. Pharmacological Research. 113: 81-91. PMID 27544651 DOI: 10.1016/J.Phrs.2016.08.022 |
0.714 |
|
| 2016 |
Gregorio DD, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G. PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors The International Journal of Neuropsychopharmacology. 19: 32-32. DOI: 10.1093/Ijnp/Pyw041.361 |
0.683 |
|
| 2015 |
Posa L, Accarie A, Noble F, Marie N. Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26390873 DOI: 10.1093/Ijnp/Pyv108 |
0.713 |
|
| Show low-probability matches. |